Economic evaluation of prostate cancer screening with prostate-specific antigen. - Wikidata - awgldk - TriplyDB

Economic evaluation of prostate cancer screening with prostate-specific antigen.

Economic evaluation of prostate cancer screening with prostate-specific antigen.

http://www.wikidata.org/entity/Q37124961

about

Screening for prostate cancer Screening for prostate cancer Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.The relevance of the procedures related to the physiotherapy in the interventions in patients with prostate cancer: short review with practice approach.Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.Economic evaluation of prostate cancer screening: a systematic review.Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models.

P2860

Q24201690-FE82B263-5137-40FA-8F28-530EE55A7183 Q24245476-64F7C7B6-EAF0-44AE-865E-DF4E44630EC2 Q33399255-8126E6E3-4BB5-4AC7-BB0C-AC256F3F5DC9 Q33882588-0EC96D08-E80D-48E6-9175-2826AD1A85CD Q35541638-8F415B61-1A6C-44DB-A07C-E3B87693D16A Q36975113-199663D7-9BA3-4B2A-ABF7-ED0A5534E135 Q38352868-EB9F1123-B42B-41FD-8691-3E7459211C86 Q48217159-F15A85C2-C2A7-4BD1-9E42-1DBDD4B46DF7

P2860

Economic evaluation of prostate cancer screening with prostate-specific antigen.

http://www.wikidata.org/entity/Q37124961

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@en

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@nl

type

label

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@en

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@nl

prefLabel

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@en

Economic evaluation of prostate cancer screening with prostate-specific antigen.

@nl

P1433

Q37124961-6C4EAF95-5BB2-42B6-A3C1-FA3F8515BC09

P1476

Q37124961-6C0181F5-662E-4D6A-8ABE-ED0EBB42788F

P2093

Q37124961-83F3A03F-B5C9-44DB-B5A0-7287CCCC0560

P2860

Q37124961-0D14707C-11E9-45DE-B36A-0A17FE031A87

Q37124961-32C2DDD0-A48D-4843-BC68-B79E220F2117

Q37124961-4A9D8DFE-E3A9-4AA0-A8AB-96E33007F06B

Q37124961-4B25E72B-ECE7-4AF3-8A58-9F8E0674008C

Q37124961-601CBC38-ED35-4775-8988-D4626AE40B5D

Q37124961-7B97FEB1-281B-460A-9C72-158127C8F451

Q37124961-86DA4347-5D82-4A5D-AA89-47C593AF0F30

Q37124961-928F2658-95E4-406F-8744-AD0F69D25811

Q37124961-B97101FE-E912-40D2-80EE-40EDA9B64A88

Q37124961-C2AA0969-11B6-40D4-84BA-DD3DE95FDC39

P304

Q37124961-30434508-C69C-46F7-A13C-F4FBA532AF64

P31

Q37124961-C96BC33B-AF65-4308-A66C-96B9946C0358

P356

Q37124961-1BBDC1BE-84E7-43DC-AAD7-C112105DC8E6

P433

Q37124961-B953910F-CCF3-442C-94CB-E96B2C7DBDF8

P478

Q37124961-70E0620C-2051-4F64-AC63-13ACB5A00A52

P50

Q37124961-F8FCFE76-3734-4948-9AA6-99061463CFE2

P577

Q37124961-1AB62585-A938-4316-BD82-EC1D3AC4E5B5

P5875

Q37124961-8FE5B245-CEB2-4A71-9A34-07551A7765F0

P698

Q37124961-CCF1BA8A-9CF9-45E7-87C8-9C77A2EE8F99

P356

J.1442-2042.2008.02013.X

P1433

International Journal of Urology

P1476

Economic evaluation of prostate cancer screening with prostate-specific antigen

@en

P2093

Tomoaki Imamura

http://www.w3.org/2001/XMLSchema#string

P2860

The contingent valuation method in health care.

Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening.

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Decision analysis and Markov modeling in urology.

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

Costs and effects of prostate cancer screening in Sweden--a 15-year follow-up of a randomized trial.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

An evaluation of prostate-specific antigen as a screening test for prostate cancer.

P304

285-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1442-2042.2008.02013.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5471476

http://www.w3.org/2001/XMLSchema#string

P698

18380812

http://www.w3.org/2001/XMLSchema#string